Tue, Feb 25, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

BarclayHedge: Hedge funds gain +0.42% in August

Wednesday, September 12, 2018

Laxman Pai, Opalesque Asia:

Hedge Funds gained 0.42% in August 2018 versus a 3.26% increase in the S&P 500 Total Return Index, according to the Barclay Hedge Fund Index.

A press release from BarclayHedge said that year to date, the Barclay Hedge Fund Index is up 1.55%, while the S&P has gained 9.94%.

Sol Waksman, founder and president of BarclayHedge said that new all-time highs for the S&P 500 and Nasdaq coupled with a rally in US Treasuries helped set the stage for another profitable month for hedge funds.

Overall, 15 of Barclay's 17 hedge fund indices gained ground in August, while two had losses.

The Healthcare & Biotechnology Index was up 5.21% in August, and now has five consecutive months of gains. Distressed securities were up 1.88%, Equity Long Bias gained 1.40%, Equity Market Neutral was up 0.61%, and the Equity Long/Short Index added 0.48%.

In the loss column, Emerging Markets were down 2.12% and European Equities gave up 0.30%.

"Monetary tightening in the US, trade war worries, and an overabundance of USD denominated debt has wreaked havoc on emerging market currencies," Waksman added. "Contagion concerns are in the air."

At the end of August, 13 hedge fund indices had positive returns for the year, while four have lost ground.

The Healthcare & Biotechnology Index has outpaced all other hedge fund indices with a strong 17.42% return. The Technology Index has gained 10.06%, Distressed Securities are up 8.96%, Equity Long ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. PE/VC: Venture debt: Is it a loan? Is it equity? Is it an pportunity?, PE, VC investments in India hit all-time high in 2019[more]

    Venture debt: Is it a loan? Is it equity? Is it an pportunity? From Forbes: Venture Capital is usually the default option for fast-growth startups looking for a cash injection, thanks to our willingness to take risks in return for equity, and with no need to pay anything back - at least

  2. Other Voices: Evolution of shrinking hedge fund fees - what do investors and managers need to know?[more]

    By Don Steinbrugge, Founder and CEO, Agecroft Partners (DonSteinbrugge@agecroftpartners.com): Hedge funds fees remain under extreme pressure across the industry. This strong trend is driven by declining return expectations from investors, inc

  3. COVID-19: Investors track ships, chase rumours to get edge on COVID-19 risks, Coronavirus risk puts the bull run on pause, China was wise to let markets stumble[more]

    Investors track ships, chase rumours to get edge on COVID-19 risks From Reuters: As investors crunch numbers to determine how the coronavirus will hit China's economy, hedge fund manager Nathaniel Polachek has tied much of his outlook to the fate of a ship anchored near Weihai, China.

  4. Bruce Berkowitz is back!, Coatue's new quant fund lost money in the fourth quarter[more]

    Bruce Berkowitz is back! From Institutional Investor: Famed value investor Bruce Berkowitz has hit hard times over the past decade, with big bets on losers like Eddie Lampert's Sears Holdings. In fact, over the past 10 years, his Fairholme Fund's annualized return is only 4.89 percent -

  5. Are all ESG Indexes as green as you want them to be?[more]

    From Beyond Investing: When Laurence Fink, chief executive of BlackRock, with nearly US$7 trillion under management, vows to put sustainability at the core of the firm's new investment approach, markets and investors sit up and liste